Epirubicin (Ellence)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Epirubicin (Ellence), covering 2010-03-26 to 2013-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 3]